Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Are we all just watching and waiting for just one product
Or does this company actually have anything else generating substantial incomes
If you were invested, you'd have done that research already and have no requirement to ask the question.
Suggest you do a bit of research Wayne as your question (in the context of this Co.) doesn't make sense. There have been plenty of good updates in the last few days. Check out Seaboy's post from yesterday as that will give you some idea of what is going on here. GLA
Wayne, notice how the cult is already aggressive towards you, yet not a single one of them answered your question [because they are in denial about the answer].
No disrespect or motive behind this question but Big, why are you still here ?
Because he's a brainless f**kwit
matt - in fairness, I think the question was in relation to SNG having 1 drug, all three trials and potential stockpiling you mentioned do rely on the success of this one drug. The asthma and COPD trials would have to be restarted through to completion which could take well into next year and beyond, so overall it's a valid concern and therefore a valid question.
matt,
OP's Q is whether there's any other products. Read the Q before you try to answer it, ok.
So,
- 3 Trials - are we trialling 3 different products? Or is it the same product?
- Potential of stockpiling another product? Or still the same juice as in point 1?
- Asthma potential - please, at least don't lie to yourself.
- COPD potential - valued at 10p before dilution? How close is it to generating cash (timeframes please)
- LOXL2 - valued at?
Do you really think COPD and LOXL are enough to justify current mcap?
Are you really that blinkered?
@Alina
A broad spectrum therapeutic anti-viral treatment in time not just the few mentioned.
There is no restarting to completion. They have to do the phase 2 again until they have conditions under which the trials can generate good enough data to progress to phase 3.
noguts - replied multiple times (ffs, somebody add this to your cult page) - still holding a small amount as I hope the yanks play will work out. Probably more out of sentimental value rather than a rational decision to gamble on this company. This doesn't mean that I'm not allowed an opinion about how this company has been mismanaged since manic monday.
Nogutsnoglory - Although there has been much talk about SNG001 as a broad based antiviral I would imagine this would require further trials to confirm. It has of course only been trialled against Covid so far.
noguts - broad spectrum therapeutic - is that a different product then? Has that been proven in any trials? How close is this to generating cash (timelines please).
And after all these replies, it is I, who is a pathetic excuse for a man.
SNG will never get approved for testing COVID.
I rest my case.
Mr big mouth did you lose money when you sold out
Every weekend u get one ass hole who comes out with s...t
Don't bother answering the OP, waste of typing juice.
This golden nugget from his posting history "...I thought I’d take a punt when some twxt said yep it’s a 20 bag easy lol..." . One trick pony, too right Wayno.
All proper LTH's both here and in the 'cult' are aware of the value of the product and company, and are willing to wait the required amount of time for synairgen to prove themselves to the masses.
For a small company that has no support from our crooked government, they're doing exceptionally well and moving through trials at great speed - even though it might not seem like it to most.
Have some more patience, all genuine investors. I believe news will drop in 1-2 weeks.
Lurker - some are not even aware that SNG is a treatment, not a test.
Clearly you're not one of them. Read your own post.
Then I'd say that that's a simple case of not doing any research on the company tbh.
I used to have respect for you Big, as mu" as you can in a forum. Accuse me of being part of the cult if you want but I speak my mind. Pretty sure I can guess your response since I think I have your measure as a man. Not that big.
Rum - the problem I have with the cult is
(a) They attack anyone who has a different point of view (Which is that SNG is guaranteed to hit £50, probably on Monday)
(b) They actively spread misinformation. This thread is a very good example.
Just re-read the replies of moron007 to get the idea. Zero (I repeat, zero!) understanding of the company's product. And I am not referring to his typo about testing, although I had a chuckle. He can't grasp that there is only one product in one application than can justify current mcap IF IT MAKES IT TO THE MARKET. The rest is so far down the line from commercialising (even if it works, big question mark) that it can be valued at close to zero (COPD play alone was sub 10p before dilution. Zero understanding of risks. Zero understanding of the potential upside. Zero understanding of the investment game as a whole. He probably does not know what mcap is.
But oh boy, is he good at yapping.
MR Big, you and Scinv would be surprised to know that the "cult" has many discussions about concerns on many topics, it's healthy. The difference with the "cult" is that it's all done with dignity and respect, something you seem to have lost all of on this board now.